CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway

Cancer Research

Volumn 70, Issue 19, 2010, Pages 7489-7499

  Trimmer, Casey ^a,b   Whitaker Menezes, Diana ^b   Bonuccelli, Gloria ^b   Milliman, Janet N ^a   Daumer, Kristin M ^a   Aplin, Andrew E ^a   Pestell, Richard G ^a   Sotgia, Federica ^a   Lisanti, Michael P ^b   Capozza, Franco ^a,b,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c ROMA TRE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CAVEOLIN 1; FOCAL ADHESION KINASE; INTEGRIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; CAVEOLIN 1; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; LUNG NEOPLASMS; MELANOCYTES; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 77957339515     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0900     Document Type: Article

References (45)

1. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-8.
2. Palade GE, Bruns RR. Structural modification of plasmalemma vesicles. J Cell Biol 1968;37:633-49.
3. Pearse BM. Clathrin: a unique protein associated with intracellular transfer of membrane by coated vesicles. Proc Natl Acad Sci U S A 1976;73:1255-9.
4. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 2004;84:1341-79. (Pubitemid 39287953)
5. Tang Z, Scherer PE, Okamoto T, et al. Molecular cloning of caveolin- 3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996;271:2255-61. (Pubitemid 26047818)
6. Garcia-Cardena G, Martasek P, Siler-Masters BS, et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: functional significance of the NOS caveolin binding domain in vivo. J Biol Chem (Communication) 1997;272:25437-40. (Pubitemid 27438846)
7. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, andmetastasis. Am J Physiol Cell Physiol 2005;288:C494-506.
8. Lisanti MP, Tang Z, Scherer PE, Kubler E, Koleske AJ, Sargiacomo M. Caveolae, transmembrane signalling and cellular transformation. Mol Membr Biol 1995;12:121-4.
9. Capozza F, Williams TM, Schubert W, et al. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am J Pathol 2003;162:2029-39. (Pubitemid 36613059)
10. Williams TM, Cheung MW, Park DS, et al. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Mol Biol Cell 2003;14:1027-42.
11. Goetz JG, Lajoie P, Wiseman SM, Nabi IR. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev 2008;27:715-35.
12. Belanger MM, Gaudreau M, Roussel E, Couet J. Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells. Cancer Biol Ther 2004;3:954-9. (Pubitemid 41351018)
13. Lavie Y, Fiucci G, Liscovitch M. Upregulation of caveolin in multidrug resistant cancer cells: functional implications. Adv Drug Deliv Rev 2001;49:317-23. (Pubitemid 32718691)
14. Felicetti F, Parolini I, Bottero L, et al. Caveolin-1 tumor-promoting role in human melanoma. Int J Cancer 2009;125:1514-22.
15. Nakashima H, Hamamura K, Houjou T, et al. Overexpression of caveolin-1 in a human melanoma cell line results in dispersion of ganglioside GD3 from lipid rafts and alteration of leading edges, leading to attenuation of malignant properties. Cancer Sci 2007;98:512-20. (Pubitemid 46562741)
16. Blackburn JS, Rhodes CH, Coon CI, Brinckerhoff CE. RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis. Cancer Res 2007;67:10849-58.
17. Valente P, Fassina G, Melchiori A, et al. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer 1998;75:246-53. (Pubitemid 28100066)
18. Capozza F, Cohen AW, Cheung MW, et al. Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells. Am J Physiol Cell Physiol 2005;288:C677-91.
19. Capozza F, Combs TP, Cohen AW, et al. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol 2005;288:C1317-31.
20. Masamha CP, Benbrook DM. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Cancer Res 2009;69:6565-72.
21. Juillerat-Jeanneret L, Dessous L'Eglise Mange P, Eskenasy-Cottier AC, Janzer RC. Direct and astrocyte-mediated effects of ethanol on brain-derived endothelial cells. Life Sci 1995;56:1499-509.
22. Rychahou PG, Kang J, Gulhati P, et al. Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc Natl Acad Sci U S A 2008;105:20315-20.
23. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
24. Hosooka T, Noguchi T, Nagai H, et al. Inhibition of the motility and growth of B16F10 mouse melanoma cells by dominant negative mutants of Dok-1. Mol Cell Biol 2001;21:5437-46.
25. Torres VA, Tapia JC, Rodriguez DA, et al. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced β-catenin-Tcf/Lef-dependent transcription. Mol Cell Biol 2007;27:7703-17.
26. del Pozo MA, Balasubramanian N, Alderson NB, et al. Phosphocaveolin- 1 mediates integrin-regulated membrane domain internalization. Nat Cell Biol 2005;7:901-8.
27. Galbiati F, Volonte D, Liu J, et al. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 2001;12:2229-44.
28. Gehlsen KR, Davis GE, Sriramarao P. Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis 1992;10:111-20.
29. Li X, Regezi J, Ross FP, et al. Integrin αvβ3 mediates K1735 murine melanoma cell motility in vivo and in vitro. J Cell Sci 2001;114:2665-72.
30. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285:1028-32.
31. Lee H, Volonte D, Galbiati F, et al. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol 2000;14:1750-75.
32. Hieken TJ, Farolan M, Ronan SG, Shilkaitis A, Wild L, Das Gupta TK. â3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res 1996;63:169-73.
33. Albelda SM, Mette SA, Elder DE, et al. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res 1990;50:6757-64.
34. Razani B, Engelman JA, Wang XB, et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001;276:38121-38.
35. Zhao J, Guan JL. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 2009;28:35-49.
36. Zhang W, Razani B, Altschuler Y, et al. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinomacells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. J Biol Chem 2000;275:20717-25.
37. Bailey KM, Liu J. Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase. J Biol Chem 2008;283:13714-24.
38. Abdel-Ghany M, Cheng HC, Elble RC, Pauli BU. Focal adhesion kinase activated by β(4) integrin ligation to mCLCA1 mediates early metastatic growth. J Biol Chem 2002;277:34391-400.
39. Kahana O, Micksche M, Witz IP, Yron I. The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma. Oncogene 2002;21:3969-77.
40. Kaneda T, Sonoda Y, Ando K, et al. Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis. Cancer Lett 2008;270:354-61.
41. Hess AR, Postovit LM, Margaryan NV, et al. Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res 2005;65:9851-60.
42. Ren XD, Kiosses WB, Sieg DJ, Otey CA, Schlaepfer DD, Schwartz MA. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J Cell Sci 2000;113:3673-8.
43. Qian F, Zhang ZC, Wu XF, Li YP, Xu Q. Interaction between integrin á(5) and fibronectin is required for metastasis of B16F10 melanoma cells. Biochem Biophys Res Commun 2005;333:1269-75.
44. Yeudall WA, Miyazaki H, Ensley JF, Cardinali M, Gutkind JS, Patel V. Uncoupling of epidermal growth factor-dependent proliferation and invasion in a model of squamous carcinoma progression. Oral Oncol 2005;41:698-708.
45. Noberini R, Pasquale EB. Proliferation and tumor suppression: not mutually exclusive for Eph receptors. Cancer Cell 2009;16:452-4.